Rehmann Capital Advisory Group - SUPERNUS PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 43 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Links
Filings
Quarter-by-quarter ownership
Rehmann Capital Advisory Group ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$33,341,000
-0.5%
34,0000.0%0.00%0.0%
Q4 2021$33,511,000–34,000–0.00%–
 Download
Other shareholders

There were no reported owners of SUPERNUS PHARMACEUTICALS INC in Q1 2022.

NameSharesValueWeighting ↓
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders